Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese Medical Industry Seeks Avenues To Globalize

This article was originally published in PharmAsia News

Executive Summary

China's export of medical products has always exceeded its import, and trade surplus of the sector hit a new high last year. However, 2007 marked a turning point as the import growth rate overtook export increase for the first time by 1.5 percent. The president for the China Chamber of Commerce of Medicines and Health Products Importers and Exporters notes that rising internal competition and the impact of various health policies coming into effect mean globalization is the way to go. In the face of more challenges, domestic companies have to innovate and develop multiple markets. Some tap into foreign investors to list on overseas stock exchanges as an internationalization strategy. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067616

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel